UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934
(Amendment No. 1)*

Elite Pharmaceuticals, Inc.
(Name of Issuer)

Common stock, $.01 par value
(Title of Class of Securities)

28659T200
(CUSIP Number)

May 31, 2008
(Date of Event which Requires
Filing of this Statement)

Check the appropriate box to designate the rule pursuant to
which this Schedule is filed:

[X] Rule 13d-1(b) For IA & IAR
[ ] Rule 13d-1(c) For LP if any
[ ] Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No. 28659T200 SCHEDULE 13G Page 2 of 6


1 Name of Reporting Person Eliot Rose Asset Management, LLC
 IRS Identification No. of Above Person 04-3649045

2 Check the Appropriate Box if a Member of a Group
 (a) [ ]
 (b) [ ]

3 SEC USE ONLY


4 Citizenship or Place of Organization

 Rhode Island

 5 Sole Voting Power

 -0-

 NUMBER OF 6 Shared Voting Power
 SHARES
 BENEFICIALLY -0-
 OWNED BY EACH
 REPORTING 7 Sole Dispositive Power
 PERSON WITH
 -0-

 8 Shared Dispositive Power

 -0-

9 Aggregate Amount Beneficially Owned by each Reporting
Person

 -0-

10 Check Box if the Aggregate Amount in Row (9) Excludes
Certain Shares* [ ]

11 Percent of Class Represented by Amount in Row 9

 0%

12 Type of Reporting Person*

 OO, IA


CUSIP No. 28659T200 SCHEDULE 13G Page 3 of 6


1 Name of Reporting Person Gary S. Siperstein
 IRS Identification No. of Above Person

2 Check the Appropriate Box if a Member of a Group
 (a) [ ]
 (b) [ ]

3 SEC USE ONLY


4 Citizenship or Place of Organization

 United States

 5 Sole Voting Power

 -0-

 NUMBER OF 6 Shared Voting Power
 SHARES
 BENEFICIALLY -0-
 OWNED BY EACH
 REPORTING 7 Sole Dispositive Power
 PERSON WITH
 -0-

 8 Shared Dispositive Power

 -0-

9 Aggregate Amount Beneficially Owned by each Reporting
Person

 -0-

10 Check Box if the Aggregate Amount in Row (9) Excludes
Certain Shares* [ ]

11 Percent of Class Represented by Amount in Row 9

 0%

12 Type of Reporting Person*

 OO, IN


 CUSIP No. 28659T200 SCHEDULE 13G Page 4 of 6


Item 1(a). Name of Issuer.

 Elite Pharmaceuticals, Inc.

Item 1(b). Address of Issuer's Principal Executive Offices.

 165 Ludlow Avenue, Northvale, NJ 07647

Item 2(a). Names of Persons Filing.

 Eliot Rose Asset Management, LLC and Gary S. Siperstein.

Item 2(b). Address of Principal Business Office or, if none,
Residence.

 The office address for Eliot Rose Asset Management, LLC and
Gary S. Siperstein is 10 Weybosset Street, Suite 401,
Providence, RI 02903

Item 2(c). Citizenship.

 Eliot Rose Asset Management, LLC is a Rhode Island limited
liability company, Gary S. Siperstein is a United States
citizen.

Item 2(d). Title of Class of Securities.

 Common stock, $.01 par value

Item 2(e). CUSIP Number.

 28659T200

Item 3. If this statement is filed pursuant to 240.13d-1(b)
or 240.13d-2(b) or (c), check whether the person filing is a:

(a) [ ] Broker or dealer registered under section 15 of the
Act (15 U.S.C. 78o).

(b) [ ] Bank as defined in section 3(a)(6) of the Act (15
U.S.C. 78c).

(c) [ ] Insurance company as defined in section 3(a)(19) of
the Act (15 U.S.C. 78c).

(d) [ ] Investment company registered under section 8 of the
Investment Company act of 1940 (15 U.S.C. 80a-8).


CUSIP No. 28659T200 SCHEDULE 13G Page 5 of 6


(e) [X] An investment adviser in accordance with 240.13d-
1(b)(1)(ii)(E).

(f) [ ] An employee benefit plan or endowment fund in
accordance with 240.13d-1(b)(1)(ii)(F).

(g) [X] A parent holding company or control person in
accordance with 240.13d-1(b)(1)(ii)(G). (for Gary Siperstein
only)

(h) [ ] A savings association as defined in Section 3(b) of
the Federal Deposit Insurance Act (12 U.S.C. 1813).

(i) [ ] A church plan that is excluded form the definition of
an investment company under section 3(c)(14) of the Investment
Company act of 1940 (15 U.S.C. 80a-3).

(j) [ ] Group, in accordance with 240.13d-1(b)(1)(ii)(J).

Item 4. Ownership.

 Reference is made hereby made to Items 5-9 and 11 of pages
two (2) and three (3) of this Schedule 13G, which Items are
incorporated by reference herein.


Item 5. Ownership of Five Percent or Less of a Class.

 If this statement is being filed to report the fact that as
of the date hereof the reporting person has ceased to be the
beneficial owner of more than five percent of the class of
securities, check the following [X].

Item 6. Ownership of More Than Five Percent on Behalf of
Another Person.

 Not applicable.

Item 7. Identification and Classification of the Subsidiary
which Acquired the Security Being Reported on by the Parent
Holding Company.

 Not applicable.

CUSIP No. 28659T200 SCHEDULE 13G Page 6 of 6


Item 8. Identification and Classification of Members of the
Group.

 Not applicable.

Item 9. Notice of Dissolution of Group.

 Not applicable.

Item 10. Certification.

 By signing below, Eliot Rose Asset Management, LLC and Gary
S. Siperstein certify that, to the best of their knowledge and
belief, the securities referred to above on pages two (2) and
three (3), respectively, of this Schedule 13G were acquired and
are held in the ordinary course of business and were not
acquired and are not held for the purpose of or with the effect
of changing or influencing the control of the issuer of the
securities and were not acquired and are not held in connection
with or as a participant in any transaction having that purpose
or effect.

Signature


 After reasonable inquiry and to the best of its knowledge
and belief, the undersigned certifies that the information set
forth in this statement is true, complete and correct.


DATED: June 3, 2008

 Eliot Rose Asset Management, LLC



 /S/ Gary S. Siperstein
 _____________________________
 By: Gary S. Siperstein
 its: Managing Member


 Gary S. Siperstein


 /S/ Gary S. Siperstein
 _____________________________
 By: Gary S. Siperstein

Attention: Intentional misstatements or omissions of fact
constitute Federal criminal violations (See 18 U.S.C. 1001)

Elite Pharmaceuticals (AMEX:ELI)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024 Plus de graphiques de la Bourse Elite Pharmaceuticals
Elite Pharmaceuticals (AMEX:ELI)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024 Plus de graphiques de la Bourse Elite Pharmaceuticals